AI-assisted Echocardiography for LVEF in older adults with heart failure
Official title: Relevance of Artificial Intelligence-Assisted Echocardiography for Left Ventricular Ejection Fraction Assessment in Geriatric Patients
Run by Gérond'if · NCT07701369 · Data updated 2026-11-12
This study tests whether an AI-powered automated LVEF measurement from echocardiography can match standard methods in people aged 75 and older hospitalized for acute heart failure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 75 Years and up |
| Sex | All |
| Enrollment | 130 (estimated) |
| Sponsor | Gérond'if Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | July 7, 2026 |
| Main results expected | June 30, 2028 |
| Study ends | June 30, 2028 |
| Registry record updated | July 28, 2026 |
| Trial ID | NCT07701369 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 75 years and older admitted for acute heart failure who are hemodynamically stable and able to provide informed consent.
✕Probably not a fit
Patients with hemodynamic instability, contraindications to transthoracic echocardiography, or inability to consent may not benefit from the AI-assisted approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-center interventional study compares two methods of measuring left ventricular ejection fraction in patients aged 75 years and older admitted for acute heart failure. Each participant will have two echocardiograms within 24 hours: a standard echocardiography as the reference method and an AI-assisted automated LVEF assessment (AutoEF-AI). The goal is to determine if AI-enabled measurements are reliable and reproducible in the geriatric inpatient setting. All eligible patients must be hemodynamically stable and able to consent. The study is led by Gérond'if at Broca Hospital in Paris and does not list additional collaborators.
Why it matters
Potential benefit: If successful, AI-assisted LVEF measurements could offer faster or more accessible heart function assessments for older patients, potentially guiding treatment decisions.
How similar studies have gone: Prior work suggests AI-enabled echocardiography can be accurate, but validation in older, acutely ill inpatients remains limited and this study contributes targeted geriatric data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥75 years. * Hospitalization in a geriatric unit for acute heart failure according to the 2021 ESC diagnostic criteria. * Hemodynamic stability at the time of echocardiographic examination. * Ability to understand study information, provide written informed consent, and willingness to participate. * Affiliation with, or beneficiary of, a health insurance/social security scheme. Exclusion Criteria: * Hemodynamic instability preventing echocardiographic assessment. * Contraindication to transthoracic echocardiography. * Patients under legal protection (guardianship, curatorship, or judicial protection measures) or unable to provide informed consent. * Refusal to participate in the study.
Where it's running
-
Broca Hospital
Paris, France Recruiting
Study contacts
- Principal investigator: Olivier HANON, MD PhD — Geriatric Department, Broca hospital
- Study coordinator: Isabelle DUFOUR
- Email: isabelle.dufour@gerondif.org
- Phone: +33 (0) 185781011
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.